- Home
- NNNN vs CLSK Comparison
NNNN vs CLSK Comparison
Compare NNNN & CLSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- CLSK
- Stock Information
- Founded
- NNNN 2021
- CLSK 1987
- Country
- NNNN Germany
- CLSK United States
- Employees
- NNNN N/A
- CLSK N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CLSK Finance: Consumer Services
- Sector
- NNNN Health Care
- CLSK Finance
- Exchange
- NNNN Nasdaq
- CLSK Nasdaq
- Market Cap
- NNNN 2.2B
- CLSK 2.6B
- IPO Year
- NNNN 2025
- CLSK N/A
- Fundamental
- Price
- NNNN $43.04
- CLSK $11.44
- Analyst Decision
- NNNN
- CLSK Strong Buy
- Analyst Count
- NNNN 0
- CLSK 9
- Target Price
- NNNN N/A
- CLSK $20.66
- AVG Volume (30 Days)
- NNNN 49.3K
- CLSK 18.8M
- Earning Date
- NNNN 01-01-0001
- CLSK 08-07-2025
- Dividend Yield
- NNNN N/A
- CLSK N/A
- EPS Growth
- NNNN N/A
- CLSK N/A
- EPS
- NNNN 0.06
- CLSK 0.98
- Revenue
- NNNN $8,185,146.00
- CLSK $631,937,000.00
- Revenue This Year
- NNNN N/A
- CLSK $111.14
- Revenue Next Year
- NNNN N/A
- CLSK $46.10
- P/E Ratio
- NNNN $802.78
- CLSK $11.64
- Revenue Growth
- NNNN 21.95
- CLSK 84.66
- 52 Week Low
- NNNN $5.18
- CLSK $6.45
- 52 Week High
- NNNN $55.65
- CLSK $17.97
- Technical
- Relative Strength Index (RSI)
- NNNN N/A
- CLSK 68.05
- Support Level
- NNNN N/A
- CLSK $9.81
- Resistance Level
- NNNN N/A
- CLSK $10.54
- Average True Range (ATR)
- NNNN 0.00
- CLSK 0.59
- MACD
- NNNN 0.00
- CLSK 0.27
- Stochastic Oscillator
- NNNN 0.00
- CLSK 91.59
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About CLSK CleanSpark Inc.
Cleanspark Inc is a bitcoin mining company. Through CleanSpark, Inc., and the Company's wholly owned subsidiaries, the company mines bitcoin. The company entered the bitcoin mining industry through its acquisition of ATL. Bitcoin mining is the sole reportable segment of the company.